The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Nastech Pharmaceutical Company Inc.  (NSTK) Trade Now »     Rate NSTK  -  Discuss NSTK  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
64.5%
Top:
100.0%
Rate NSTK:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

NSTK: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bearish on NSTK ... Graphic_rating_sell NSTK
17%
now mrna, but has gone from $20.00 to $.28 cents and now rebounded a little to $1.39. The most accurate forecaster on social picks since 2007 has been jimmy T. on (nstk) MRNA. agree with his analogy.
By  JIMMY T   (-13.61%  risk: moderate)  09/20/09 Comment


Bearish on NSTK ... Graphic_rating_sell NSTK
17%
AUG.21 'MRNA' STILL A WASTE OF TIME. $1.39
By  JIMMY T   (-13.61%  risk: moderate)  08/21/09 Comment


Great price on pills, for once! Graphic_rating_buy NSTK
Trip_to_berlin_146
33%
I've had my eye on this for a long time and I never thought it would get this low. This is a risky play like all pharm stocks but I feel that given the history of the company it's due for a least a little shot in the arm to at least 2.30 or so. Plus some news is suppose to be released soon about one of its cancer research projects. I hope its good news.

A target of around 1.90 would have been more realistic but, what the hell, this is the stock market and we've all been at the 'casino' lately!
By  Brady   (-18.20%  risk: moderate)  06/02/08 Comment


Bearish on NSTK ... Graphic_rating_sell NSTK
17%
NSTK:HEADING FOR $1.00 BID REAL SOON! NO MOMENTUM,NO PRODUCTS, ENIMIC VOLUME,NO PARTNERS, NO REVENUE TO SPEAK OF, LARGE EXPENSES, AND MANY FINANCIALLY DECIMATED SHAREHOLDERS ALL OVER THE PLACE. NSTK NEEDS NEW NAME, NEW SHAREHOLDERS SO MANAGEMENT CAN COLLECT SALARIES FOR ANOTHER 24 YEARS.
By  JIMMY T   (-13.61%  risk: moderate)  05/22/08 Comment


my continuing evaluation from 12 months ago Graphic_rating_sell NSTK
17%

NSTK:  BEING IN BUSINESS FOR 24 YEARS, BECOMING ACQUAINTED WITH BROKERAGE HOUSES, RESEARCH FRMS, STAR MINE ANALYSTS, AND THE REST OF THE CIRCLE OF EVERYDAY BUSINESS

ASSOCIATES OF WALL STREET, IT CAN BE UNDERSTOOD HOW FUNDS, RESEARCH FIRMS, AND ANALYSTS,

COULD FIND IT QUITE EASY TO PLAY FAVORITISM OR SORT OF GO WITH THE FLOW IN PARTICIPATING IN

<> <> RECOMMENDING A SPECIFIC STOCK. STILL AT THIS POINT IN TIME, 5/15/08 RESEARCH FIRMS, THEIR TARGET PRICES AND STAR MINE ANALYST ARE STILL PLUGGING NSTK AND MANY HAVEN'T ADJUSTED THEIR TARGET PRICES AS OF YET. SINCE THE ...
By  JIMMY T   (-13.61%  risk: moderate)  05/15/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
JPM JPMorgan Chase & Co
NVDA NVIDIA Corp
SBUX Starbucks Corp
GM General Motors Corp
INTC Intel Corp
BA The Boeing Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on NSTK

Visit streetinsider.com


Discussion Wall + Add  
crsathish   (+1.83%  risk: aggressive)


More Resources

Graphic_arrow1 About Nastech Pharmaceutical Company Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch